Anavex Life Sciences Corp (AVXL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $86.53M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 52.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 22.1, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about AVXL
News
AVXL Valuation
AVXL Profitability: Margins, ROIC and FCF
Anavex Life Sciences (AVXL) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -12.8%
Anavex Life Sciences Competitors
Peers by sector and size for Anavex Life Sciences (AVXL) include Forian, Nkarta and Seer.
Sector: Healthcare
AVXL Bull Case vs Bear Case
Bull case
- AVXL beat EPS estimates in 75.0% of its last 8 reported quarters.
AVXL Earnings: Beat Rate and Next Report
Anavex Life Sciences (AVXL) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Nov 23, 2026.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- 27.1%
- EPS estimate (fiscal period ending Sep 30, 2026)
- -$0.11
AVXL Earnings Date
AVXL reports Nov 23, 2026. The date is estimated.
AVXL Earnings Call
The latest AVXL earnings call transcript on file is labeled 2026Q1.
Read the 2026Q1 transcriptAVXL ETF Holders
GNG tracks 8 ETFs that hold AVXL. The largest weights:
- iShares Russell 2000 ETF (IWM), 0.03% of the fund
- iShares Biotechnology ETF (IBB), 0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), 0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Updated Aug 28, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About AVXL
When does AVXL report earnings?
Anavex Life Sciences Corp (AVXL) is expected to report earnings on Nov 23, 2026.
Does AVXL pay dividends?
Anavex Life Sciences Corp (AVXL) does not currently pay a regular dividend.
What is AVXL's market cap?
Anavex Life Sciences Corp (AVXL) has a market capitalization of $86.53M with a current stock price of $0.82.
AVXL pages: Overview, Earnings, Forecast, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.